Updated:
Diamond BioFund
Diamond BioFund is Taiwan's first listed sustainable biotechnology venture capital firm. Founding shareholders include 中天生技, 富邦金控, 台新金控 and 潤泰集團.
Overview
Diamond BioFund is Taiwan's first listed sustainable biotechnology venture capital firm. Founding shareholders include 中天生技, 富邦金控, 台新金控 and 潤泰集團. The firm focuses on biotech and healthcare investments—including new drug R&D, advanced medical devices, innovative medical services, medical channels and agricultural biotech—and has invested in and incubated more than 20 biotech startups in Taiwan and abroad. It assists portfolio companies on governance, R&D, clinical execution, commercial development and capital-market access to accelerate value creation for shareholders.
General information
Firm type
Private Equity
Year founded
2013
Location
Region
Asia
Country
Taiwan
City
Taipei City
Corporate office
Taipei City, Taiwan
Principals
李祖德，副董事長
Sector focus
Frequently asked questions
What investment stages does Diamond BioFund typically target?
The firm targets balanced, early-stage seed, start-up, growth, succession, and general venture opportunities.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: